News News Select Year All Years 2026 (25) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 497 Results Page 1 of 5012345...102030...»Last » June 29, 2026 DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing June 23, 2026 DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index June 9, 2026 DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference June 8, 2026 DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 June 3, 2026 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting June 2, 2026 DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy May 13, 2026 Combined General Meeting of June 3, 2026 May 12, 2026 DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq April 30, 2026 DBV Technologies Reports First Quarter 2026 Financial Results Page 1 of 5012345...102030...»Last »
